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Small ubiquitin-like modifier (SUMO) conjugation is a
reversible post-translational modification process implicated in
the regulation of gene transcription, DNA repair, and cell cycle.
SUMOylation depends on the sequential activities of E1 activat-
ing, E2 conjugating, and E3 ligating enzymes. SUMO E3 ligases
enhance transfer of SUMO from the charged E2 enzyme to the
substrate. We have previously identified PIASy, a member of the
Siz/protein inhibitor of activated STAT (PIAS) RING family
of SUMO E3 ligases, as essential for mitotic chromosomal
SUMOylation in frog egg extracts and demonstrated that it can
mediate effective SUMOylation. To address how PIASy cata-
lyzes SUMOylation, we examined various truncations of PIASy
for their ability to mediate SUMOylation. Using NMR chemical
shift mapping and mutagenesis, we identified a new SUMO-in-
teracting motif (SIM) in PIASy. The new SIM and the currently
known SIM are both located at the C terminus of PIASy, and
both are required for the full ligase activity of PIASy. Our results
provide novel insights into the mechanism of PIASy-mediated
SUMOylation. PIASy adds to the growing list of SUMO E3
ligases containing multiple SIMs that play important roles in the
E3 ligase activity.
Covalent attachment of small ubiquitin-like modifier
(SUMO)3 to target proteins is an important post-translational
modification that regulates multiple cellular processes includ-
ing transcription, nuclear transport, DNA repair, and chromo-
some segregation (1, 2). Vertebrates express at least three
functional SUMO isoforms, namely SUMO-1, SUMO-2, and
SUMO-3, that can conjugate to other proteins. SUMO-1 shares
less than 50% sequence identity to other isoforms, whereas
SUMO-2 and SUMO-3 are virtually equivalent with 97%
sequence identity and are commonly referred to as SUMO-2/3
(1–3). Similar to ubiquitylation, SUMO proteins are typically
conjugated to the target lysine residue of the substrate by the
sequential action of three enzymes: an E1 activating enzyme
(Uba2/Aos1), an E2 conjugating enzyme (Ubc9), and an E3
ligase. A SUMO E3 ligase stabilizes and optimally positions the
thioester-charged E2-SUMO complex to catalyze the transfer
of SUMO from charged E2 to the substrate (2–5).
SUMOylation utilize the same E1 and E2 enzymes; however,
different classes of SUMO-specific E3 ligases have been identi-
fied (2, 3). Among these are the protein inhibitor of activated
STAT (PIAS) protein family and its yeast homolog Siz (4),
RanBP2 (5, 6), Pc2 polycomb protein (7), and ZNF451 (8, 9). We
have previously shown that PIASy, a member of the PIAS pro-
tein family, is essential for SUMO-2/3 conjugation of mitotic
chromosomal proteins DNA topoisomerase II (TopoII) and
poly(ADP-ribose) polymerase 1 (PARP1) and demonstrated
that PIASy can efficiently catalyze SUMOylation of these sub-
strates in reconstituted reactions as well (10 –12).
Most known SUMO E3 ligases possess one or more SUMO-
interacting motifs (SIMs) that mediate non-covalent interac-
tions with SUMO (2, 3, 5–9, 13). SIMs are required for the E3
ligase activity and play an important role in positioning the
donor SUMO from the E2-SUMO complex for efficient SUMO
discharge and catalysis. SIMs consist of a core sequence of three
or four hydrophobic aliphatic residues (isoleucine, leucine, and
valine) with an acidic or polar residue at position 2 or 3, forming
a triad or tetrad core sequence of (V/I)X(V/I)(V/I) or (V/I)(V/
I)X(V/I/L) (where X is usually Asp, Glu, or Ser) (6, 14 –16). The
hydrophobic core of SIM is often flanked by a stretch of acidic
amino acids that promote electrostatic SUMO-SIM interac-
tions (14, 17). Structural studies of SUMO-SIM complexes have
demonstrated that SIM peptides adopt a parallel or antiparallel
-strand conformation upon binding to SUMO in a hydropho-
bic groove formed by the 2-strand and 1-helix (5, 14, 17, 18).
The PIAS and Siz families of SUMO E3 ligases (2, 4, 10, 13)
contain several conserved regions (see Fig. 1A) such as an
N-terminal SAP (scaffold-associating region/Acinus/PIAS)
domain involved in binding AT-rich DNA, a PINIT domain
important for substrate recognition and subcellular localiza-
tion, an SP-RING needed for interaction with the E2 Ubc9, and
a C-terminal SIM needed for binding SUMO (2, 3, 13). Cur-
rently, PIASy is known to contain one SIM at the C-terminal
region (4, 13). We report here the identification of a second SIM
in PIASy, positioned between the SP-RING and the previously
known SIM. NMR spectroscopy and mutational analysis
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revealed the significance of the new SIM in PIASy-mediated
SUMO conjugation.
Results
SUMO ligase activity of C-terminal truncations of PIASy
We have previously demonstrated the crucial role of PIASy
in SUMO-2/3 modification of mitotic substrates TopoII and
PARP1 (10 –12). Our initial deletion analysis of PIASy has
shown that both N- and C-terminal regions of PIASy are essen-
tial for its activity (10). Although we demonstrated that the N
terminus is required for localization of PIASy at the mitotic
centromeres (19), the role of the C terminus of PIASy is unclear.
To evaluate the role of the C-terminal domain of PIASy in
SUMOylation, we tested C-terminal deletions of PIASy (Fig.
1A) in the reconstituted in vitro SUMOylation assay (11). At
physiological concentration of the SUMOylation enzymes,
PIASy N414 (a fragment lacking the 87 C-terminal residues)
was inefficient in SUMOylating both TopoII and PARP1 (Fig.
1, B and C). The extent of SUMO conjugation using N414 was
similar to the SUMOylation observed in the absence of PIASy
(depicted by comparable higher shifted bands with N414 and
no PIASy for both TopoII and PARP1; Fig. 1, B and C, last two
lanes). Next, we examined a longer PIASy construct, N454, that
lacked the currently known SIM (here after referred as original
SIM) but retained all the components previously reported as
sufficient for the ligase activity of Siz1, the PIAS homolog in
yeast (4, 20). Surprisingly, N454 lacking the original SIM was
capable of SUMOylating both the mitotic substrates (Fig. 1, B
and C) albeit at a lower efficiency compared with full-length
PIASy (WT). Consistent with the previous observation in Siz1
(4), inclusion of the original SIM and the flanking acidic domain
(PIASy N480) further enhanced the SUMO conjugation (Fig. 1,
B and C).
PIASy lacking the original SIM interacts with SUMO
Both PIASy N414 and N454 could recruit E2 Ubc9 through
the SP-RING domain; however, only N454 stimulated in vitro
SUMO conjugation as an active ligase (Fig. 1). Previous studies
have revealed that efficient E3-mediated SUMO conjugation
requires optimal positioning of both E2 and SUMO from the
E2-SUMO thioester complex (4, 5, 8, 9, 21). To determine
whether the original SIM-less N454 orients the E2-SUMO
complex for productive catalysis by additional stabilization of
SUMO, we tested the direct binding between SUMO and the
original SIM-less PIASy using NMR spectroscopy. A shorter
construct, PIASy(287– 454) (Fig. 2A), was more amenable for
NMR studies due to better expression compared with N454 and
was thus used in the NMR titrations. 15N-Labeled SUMO-3
was titrated with increasing concentrations of unlabeled
PIASy(287– 454) at 1:0, 1:0.5, 1:1, and 1:2 molar ratios, and the
titration was monitored by acquiring 2D 1H-15N HSQC spectra
(Fig. 2B). The stepwise addition of PIASy(287– 454) resulted in
peak broadening of specific resonances of SUMO-3 (Fig. 2B),
indicating interaction in the intermediate exchange NMR time
scale. To identify the SUMO-3 residues that were perturbed the
most by PIASy(287– 454), we calculated the peak intensity ratio
(I1:1/I1:0) for each non-overlapped SUMO-3 peak at a SUMO-
3:PIASy(287– 454) molar ratio of 1:1 (Fig. 2C). Residues dis-
playing significant peak intensity reduction (average intensity
minus the standard deviation) included Ser-27, Gln-30, Phe-31,
Lys-41, Leu-42, Ala-45, Tyr-46, Asp-62, Glu-78, and Thr-82.
The affected residues were mapped onto the structure of
SUMO-3 (Fig. 2D). Surprisingly, even though PIASy(287– 454)
lacks the original SIM, the majority of the affected residues
clustered together spatially in the 2-strand and 1-helix of
SUMO-3, which have been well characterized as the binding
surface for the SIM on SUMO (6, 14, 17, 18). Our NMR results
suggested the existence of another SIM in PIASy within resi-
dues 287– 454.
Furthermore, results of a fluorescence polarization binding
assay using SUMO-3 labeled with fluorescein maleimide and
PIASy(287– 454) showed an apparent Kd of 81 M (Fig. 2E). The
value obtained is consistent with the observed intermediate
exchange NMR behavior and previously reported dissociation
constants for other SUMO-SIM interactions, which are in the
1–120 M range (6, 9, 14, 18, 22).
We also titrated a longer construct containing the original
SIM, PIASy(287–501), into 15N-labeled SUMO-3 (Fig. 3A). As
Figure 1. In vitro SUMO E3 ligase activity of C-terminal deletions of PIASy.
A, schematic diagram showing the conserved domains of the Siz/PIAS family
of E3 ligases. Solid lines indicate the PIASy truncation constructs tested in the
SUMOylation assay. The time courses for in vitro SUMOylation of TopoII (B)
and PARP1 (C) using WT PIASy and various truncation constructs of PIASy
(N480, N454, and N414) as well as in the absence of PIASy () are shown.
SUMOylated and unmodified forms of TopoII and PARP1 are indicated as are
the various PIASy constructs used.
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expected, incorporation of the original SIM and the acidic
domain resulted in more pronounced chemical shift perturba-
tions when compared with results of the NMR titrations using
the shorter PIASy(287– 454) (Fig. 3B). Stepwise addition
of PIASy(287–501) caused a concentration-dependent de-
crease in intensities of SUMO-3 peaks. Some SUMO-3
residues showed changes in peak positions in addition to
reduced peak intensities (e.g. Arg-35, Lys-41, Tyr-46, and Asn-
67), and several peaks broadened beyond detection (Fig. 3B).
Although most SUMO-3 residues showed some degree of line
broadening from the beginning of the titration, which is not
uncommon with the formation of a high molecular mass com-
plex (SUMO-3, 13 kDa; PIASy(287–501), 28 kDa) slowing
down the tumbling rate (23), specific residues were more
affected than the others as illustrated by a peak intensity ratio
graph (Fig. 3C). The SUMO-3 residues strongly affected by
PIASy(287–501) were identical to the residues affected by
PIASy(287– 454) and mapped to the 2-strand and 1-helix,
which form the SIM-binding surface on the SUMO (Fig. 3D).
Identification of a new SIM in PIASy
NMR titrations of 15N-labeled SUMO-3 with PIASy(287–
454), which lacked the original SIM (Fig. 2), also perturbed the
same SUMO-3 residues that a SIM peptide would, suggesting
that an additional SIM may be present within the PIASy(287–
454) fragment. Furthermore, a SIM prediction web server (24)
suggested that there is a high probability that the PIASy(287–
454) fragment contains a SIM (herein termed as new SIM)
within residues 417– 435 (Fig. 4A). The new SIM harbors a
conserved hydrophobic core with the sequence “ILVL” from
amphibian to mammalian PIASy and “VVDI” in fish PIASy and
is preceded by a few acidic and serine residues, which are poten-
tial sites for phosphorylation (Fig. 4A). These features of the
new SIM are similar to the characteristic known SIM sequences
that bind SUMO in antiparallel orientation (9, 14, 15, 22). How-
ever, unlike known SIMs, the new SIM lacks a long stretch of
acidic residues. (The acidic stretch in PIAS proteins varies from
5 to 7 residues, but the acidic stretch in PIASy is exceptionally
long with 17 residues following the known SIM.)
Figure 2. Analysis of the interaction of SUMO-3 with PIASy lacking the original SIM. A, PIASy schematic as in Fig. 1A with the solid line indicating the
fragment, residues 287– 454, used in the NMR and FP experiments. B, 2D 1H-15N HSQC spectra of 15N-labeled SUMO-3 titrated with increasing molar ratios of
PIASy(287– 454). Expanded sections of representative SUMO-3 residues affected upon binding of PIASy(287– 454) are shown on the right. C, plot of relative
peak intensity for all assigned, non-overlapping SUMO-3 resonances in the ligand-bound versus -free form (I1:1/I1:0). Gray and red lines depict mean and one
standard deviation from the mean (1), respectively. D, SUMO-3 residues displaying significant peak intensity reduction upon complex formation with
PIASy(287– 454) are highlighted red. E, fluorescence polarization binding assay of fluorescein maleimide-labeled SUMO-3 titrated with increasing concentra-
tions of PIASy(287– 454). mP, change in millipolarization. Error bars represent S.D.
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To confirm the role of the new SIM in SUMO binding, we
subcloned and expressed a 45-residue peptide encompass-
ing the PIASy region containing the new SIM fragment
(PIASy(409 – 454) WT; Fig. 4A). We also mutated the three
critical ILV hydrophobic residues of the new SIM into triple
alanines (PIASy(409 – 454) mut; Fig. 4A). Both WT and mut
PIASy(409 – 454) showed greater stability and solubility in
comparison with the longer PIASy fragments used for NMR
that contained the SP-RING and were thus ideal for NMR stud-
ies. NMR titrations using 15N-labeled SUMO-3 with either WT
or mut PIASy(409 – 454) were used to test the role of the ILV
hydrophobic residues in the new SIM in binding SUMO-3. The
WT fragment resulted in concentration-dependent changes in
peak positions of SUMO-3 resonances (Fig. 4, B and C), indi-
cating PIASy(409 – 454) WT interaction with SUMO-3 at the
fast exchange NMR time scale. In contrast, NMR titrations with
the mut fragment barely induced any discernible chemical shift
perturbations on SUMO-3 (Fig. 4, D and E), indicating that
mutating the ILV residues of the new SIM into triple alanines
interfered with SUMO-3 interaction. Analysis of the weighted
chemical shift deviations (CSDs; Fig. 4F) identified that
the strongly affected SUMO-3 residues upon binding of
PIASy(409 – 454) WT are clustered near the known SIM-bind-
ing groove of SUMO-3 (Fig. 4G). These results highlight the
importance of the ILV hydrophobic residues of the new SIM in
PIASy-SUMO recognition.
We also titrated 15N-labeled SUMO-3 with a longer con-
struct, PIASy(409 –501), which contains both the new SIM and
the original SIM plus the acidic domain (Fig. 5A). Similar to the
earlier titrations, identical SIM-binding residues of SUMO-3
were most strongly perturbed upon the addition of PIASy(409 –
501) (Fig. 5, B, C, and D). Comparison of the results of NMR
titrations of SUMO-3 with PIASy(409 –501) (where both SIMs
are present) and PIASy(409 – 454) (where only the new SIM is
present) indicated that the presence of both SIMs conferred a
higher magnitude of change in the chemical shift perturbations
of specific SUMO-3 resonances even at a lower ligand concen-
tration. Important SUMO-3 SIM-binding residues (such as
Gln-30, Phe-31, Leu-42, Ala-45, and Tyr-46) showed severe
peak intensity reduction starting at 1:0.25 molar ratios and
complete peak broadening at a 1:0.5 molar ratio (Fig. 5, B and
C), indicating binding in the intermediate exchange NMR time
scale.
The new SIM is crucial in PIASy-mediated SUMOylation
To evaluate the significance of the new and original SIMs for
the E3 ligase activity of PIASy, we mutated the three essential
core residues of the new and original SIMs into alanines (Fig.
6A). Three full-length PIASy constructs with multiple alanine
mutations were introduced in the original SIM (construct
O-SIM; Fig. 6A), the new SIM (construct N-SIM), and both
new and original SIMs (construct W-SIM). The mutants were
Figure 3. NMR titrations of SUMO-3 and PIASy(287–501) containing both original and new SIMs. A, schematic of PIASy with the solid bar indicating the
fragment 287–501 used in the experiment. B, 2D 1H-15N HSQC spectra of 15N-labeled SUMO-3 titrated with increasing amounts of PIASy(287–501). Expanded
sections of selected SUMO-3 residues affected by PIASy(287–501) are shown on the right. C, relative peak intensity graph for SUMO-3 resonances in the
ligand-bound versus -free state (I1:0.25/I1:0) where gray and red lines correspond to the mean and one standard deviation from the mean (1), respectively. D, the
SUMO-3 residues affected upon binding of PIASy(287–501) are highlighted (red, significant peak intensity reduction; orange, significant change in the peak
position). Error bars represent S.D.
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examined for their ability to facilitate SUMOylation of TopoII
and PARP1 in the in vitro SUMOylation assay (Fig. 6, B and C).
Mutation of the hydrophobic core of original SIM (O-SIM)
did not interfere with the E3 ligase role of PIASy and exhibited
high SUMOylation levels close to the wild-type PIASy for both
TopoII and PARP1 (Fig. 6, B, C, D, and E). However, mutation
of the new SIM (N-SIM) resulted in less efficient SUMOyla-
tion of TopoII (Fig. 6, B and D) and significantly low SUMOy-
lation of PARP1 compared with the WT PIASy (Fig. 6, C and E).
Furthermore, mutation of both the original and new SIMs
(W-SIM) significantly reduced SUMOylation of TopoII and
nearly abolished the E3 ligase activity of PIASy on PARP1 (Fig.
6, D and E). Overall, both TopoII and PARP1 showed a similar
trend in SUMOylation, displaying a reproducible reduction in
SUMOylation with the N-SIM and the W-SIM PIASy
mutants in comparison with the WT PIASy. However, the
observed effects were more distinct for PARP1 compared with
TopoII (largely due to the ability of TopoII to undergo
SUMOylation even in the absence of PIASy). Our results sug-
gest that the new SIM plays an important role in PIASy-medi-
ated SUMOylation, and both SIMs together are needed for the
full ligase activity of PIASy.
Discussion
Results of our NMR titrations and in vitro SUMOylation
assays revealed a new SIM in PIASy that was found to be essen-
tial for efficient PIASy-dependent SUMO-2/3 conjugation. In
contrast to the original SIM of PIASy (or the known C-terminal
SIM of other PIAS family members), the new SIM contains an
uninterrupted core of four hydrophobic residues and lacks the
Figure 4. Characterization of the binding of SUMO-3 and the new SIM of PIASy. A, PIASy schematic as in Fig. 1A with new SIM shown in magenta. The solid
bar corresponds to the PIASy fragment 409 – 454 (which contains the new SIM but lacks the original SIM) used in the experiment. The sequences of the WT and
mut PIASy construct are shown. B, a section of the 2D 1H-15N HSQC spectra of 15N-labeled SUMO-3 titrated with increasing molar ratios of WT PIASy(409 – 454)
demonstrates specific SUMO-SIM binding. C, expanded sections of selected SUMO-3 residues affected upon binding of WT PIASy(409 – 454). D and E, similar to
B and C for SUMO-3 titrations with mut PIASy(409 – 454). F, plots of weighted CSD from titrations of SUMO-3 with WT PIASy(409 – 454) (top) and mut PIASy(409 –
454) (bottom). Gray and red lines correspond to the mean and one standard deviation (1) from the mean, respectively. G, SUMO-3 residues that are strongly
affected by the binding of WT PIASy(409 – 454) are colored red.
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conventional extended acidic residue stretch (Fig. 4). Previous
studies of SUMO-SIM interaction have identified the impor-
tance of the hydrophobic core of SIM in SUMO binding (6, 14,
16). Consistent with these findings, our NMR results showed
that hydrophobic core residues of the new SIM are essential in
binding to SUMO-3, and mutation of these critical residues
abolishes binding (Fig. 4). Others have shown the role of the
acidic stretch surrounding the hydrophobic core of SIM in
SUMO paralog binding specificity (14). Although presence of
the negative charges in SIM has been shown to contribute more
toward SUMO-1 binding, SIMs lacking the acidic stretch pref-
erentially bind SUMO-2 (7, 14). The absence of the acidic
stretch in the new SIM, together with the essential role of the
new SIM in PIASy-mediated SUMOylation (Fig. 6), provides a
likely explanation for the preference of PIASy in conjugation of
SUMO-2/3 over SUMO-1 to substrates TopoII and PARP1
(10 –12).
To address the question of why there are two SIMs in PIASy,
the following observations are instructive. First, in addition to
the covalent interaction between the E2 conjugating enzyme
Ubc9 and SUMO to form the E2-SUMO thioester complex, the
backside of Ubc9 also recruits a second molecule of SUMO
through non-covalent interactions to form the E2-SUMO com-
plex (25, 26). Second, the E3 ligase ZNF451 exploits these inter-
actions to preferentially interact with two molecules of SUMO,
the donor SUMO from E2-SUMOD and the backside
E2-SUMO, via its dual SIMs (8, 9). In ZNF451, the first SIM plus
the inter-SIM region positions the E2-SUMOD thioester com-
plex for productive catalysis, whereas the second SIM acts as an
anchor to bind to the backside SUMO to facilitate poly-SU-
MOylation (8, 9). Finally, although PIAS proteins use the SP-
RING domain to directly bind to E2 Ubc9, others have shown
that the (original) SIM of PIAS proteins also interacts with the
backside E2-SUMO to form a non-covalent ternary complex
(27). Combining our discovery of the new SIM in PIASy with
the above observations (8, 9, 25–27), we propose a working
hypothesis that, analogously to ZNF451, the dual SIMs of
PIASy may also interact simultaneously with the donor SUMO
(E2-SUMOD) and the backside SUMO (E2-SUMO) to mediate
efficient SUMOylation.
Our results can be interpreted in line with this working
hypothesis. Our NMR titrations with a PIASy construct con-
taining both the new and original SIMs showed improved
SUMO-binding affinity (Fig. 5) compared with a shorter con-
struct consisting only of the new SIM (Fig. 4). Even with small
amounts of PIASy(409 –501) (containing dual SIMs), specific
SUMO-3 SIM-interacting residues including Gln-30, Phe-31,
Leu-42, Ala-45, and Tyr-46, were in intermediate exchange
(where peaks were broadened) (Fig. 5); however, with
PIASy(409 – 454) (containing the new SIM alone), these resi-
Figure 5. NMR titrations of SUMO-3 and PIASy(409 –501) containing both original and new SIMs. A, schematic of PIASy indicating fragment 409 –501
containing both the original SIM and the new SIM used in the experiment. B, 2D 1H-15N HSQC spectra of 15N-labeled SUMO-3 titrated with increasing amounts
of PIASy(409 –501). Expanded sections of representative SUMO-3 residues affected by the binding of PIASy(409 –501) are on the right. C, plot of relative peak
intensity for SUMO-3 resonances in the ligand-bound versus -free form (I1:0.25/I1:0). Gray and red lines depict mean and one standard deviation from the mean
(1), respectively. D, the SUMO-3 residues affected upon complex formation with PIASy(409 –501) are highlighted (red, residues displaying significant peak
intensity reduction; orange, residues with significant change in the peak position). Error bars represent S.D.
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dues were in the fast exchange NMR time scale (Fig. 4), suggest-
ing relatively weaker binding compared with PIASy(409 –501).
Because both SIMs individually bind to the same surface on
SUMO-3 through classical SUMO-SIM interactions (27), the
stronger NMR shift perturbations observed with PIASy(409 –
501) are probably reflective of a synergistic effect occurring
upon the binding of different SUMO-3 molecules to the tan-
dem SIM.
Additionally, our in vitro SUMOylation assays confirmed
that PIASy stimulated SUMO conjugation in a SIM-dependent
manner and that both SIMs are important for effective ligase
activity. Although mutation of the new SIM (N-SIM) ren-
dered SUMOylation slow and inefficient, probably implying its
role in the donor SUMO (E2-SUMOD) positioning and chain
initiation, mutation of both SIMs together (W-SIM; Fig. 6) or
deletion of the dual SIM region (N414; Fig. 1) nearly eliminated
the PIASy E3 ligase activity. In concordance, the presence of
both SIMs together resulted in the robust ligase activity of
PIASy (N480; Fig. 1). Our results suggest a hypothesis where the
SP-RING domain and the new SIM of PIASy may configure the
E2-SUMOD thioester complex, and the original SIM may
engage the backside SUMO for efficient catalysis and SUMO
conjugation by PIASy. To summarize, we have identified a new
SIM in PIASy that is critical for the efficient ligase activity of
PIASy and distinct from other members of the PIAS family that
contain a single SIM at their C terminus.
Experimental procedures
Molecular cloning
Xenopus laevis PIASy sharing 85% sequence similarity to the
human homolog (10) was used in these studies. The expression
plasmids for N-terminal His6-tagged human SUMO-2-GG,
SUMO-3-GG, and Xenopus full-length PIASy have been
described previously (10, 28). C-terminal truncations of PIASy
(N480, N454, and N414; Fig. 1) and PIASy NMR constructs
Figure 6. Functional role of the new SIM of PIASy. A, schematic of PIASy with solid bars illustrating the various SIM site-directed mutations examined in the
SUMOylation assay. The time courses for SUMOylation of TopoII (B) and PARP1 (C) using the indicated PIASy SIM mutant in the in vitro SUMO conjugation assay
are shown. SUMOylated and unmodified forms of TopoII and PARP1 along with the input PIASy are indicated. Quantification of the SUMOylation of TopoII
(D) and PARP1 (E) at the final time point of the assay is shown. Assays were performed in triplicate. Error bars represent one standard deviation, and an asterisk
indicates statistically significant differences from the WT activity.
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(PIASy(287– 454) and PIASy(287–501); Figs. 2 and 3) were
made by PCR amplification from the full-length construct and
subcloned into pET28a using the EcoRI and XhoI restriction
sites. PIASy fragments 409 – 454 and 409 –501 (Figs. 4 and 5)
were obtained by digesting PIASy(287– 454) and PIASy(287–
501) in pET28a with BamHI/XhoI, respectively, and ligated into
pET28a vector. PIASy constructs with mutations in the
SIM region (PIASy(409 – 454) mut, O-SIM, N-SIM, and
W-SIM; Figs. 4 and 6) were made using a QuikChange
mutagenesis kit (Stratagene). All mutations were verified by
DNA sequencing.
Protein expression and purification
For protein expression, plasmids were freshly transformed in
Escherichia coli BL21(DE3) cells and grown in 1 liter of culture
medium containing kanamycin at 30 g/ml. 15N-Labeled
SUMO-3 was expressed in M9 minimal medium supplemented
with 1 g of [15N]ammonium chloride. Unlabeled SUMO-3 (for
fluorescence polarization studies) and PIASy fragments (for
NMR studies) were obtained by cell growth in LB medium.
PIASy constructs containing the RING domain were also sup-
plied 0.1 mM ZnSO4 before and after induction. Cells were
grown at 37 °C until A600 was 0.7– 0.8 and induced with 0.5
mM isopropyl -D-thiogalactopyranoside, and cell growth was
continued overnight in a 15 °C shaker incubator to a final A600
2.5 (2.1 for PIASy constructs). Cells were harvested by cen-
trifugation (4000 rpm for 10 min), resuspended in 30 ml of
binding buffer (500 mM NaCl, 20 mM Tris-HCl, pH 8.0, 5 mM
imidazole), and lysed by sonication. Cellular debris was
removed by centrifugation (13,000 rpm for 10 min), and 600 l
of 5% (v/v) polyethyleneimine was added to the supernatant
to precipitate the nucleic acids. After another centrifugation
(13,000 rpm for 10 min), the supernatant was loaded to a pre-
charged Ni2 affinity column (Gold Biotechnology). The col-
umn was washed with 100 ml of binding buffer and eluted with
50 ml of elution buffer (500 mM NaCl, 20 mM Tris-HCl, pH 8.0,
250 mM imidazole). Elution fractions containing purified pro-
tein were pooled and dialyzed in NMR buffer (100 mM NaCl, 10
mM NaPO4, pH 6.8, 5 mM DTT). Proteins were concentrated
using Amicon Ultra 3000 centrifugal filter (Millipore), and con-
centrations were determined by absorbance at A280. Recombi-
nant proteins used in the SUMOylation assays, the E1 complex
(Uba2/Aos1), E2 Ubc9, PIASy (full length and truncation and
mutant constructs), PARP1, TopoII, and SUMO-2 were
expressed and purified as described previously (10 –12, 28).
In vitro SUMOylation assay
SUMOylation reactions were performed as described previ-
ously (11, 12). Briefly, 5 M SUMO-2, 2 mM ATP, 20 nM E1, 30
nM E2, 20 nM PIASy, and 500 nM T7-tagged PARP1 or TopoII
in reaction buffer (20 mM HEPES, pH 7.8, 100 mM NaCl, 5 mM
MgCl2, 0.05% Tween 20, 5% glycerol, 0.5 mM DTT) were incu-
bated at 25 °C for 60 min. Although at a lower efficiency,
TopoII can be SUMOylated in the absence of PIASy, and this
effect becomes more prominent with longer reaction times (12,
19). Therefore, to better understand the contribution of SIMs
of PIASy in TopoII SUMOylation, TopoII reactions with the
SIM mutants were incubated for up to 30 min (Fig. 6B). Ali-
quots were taken from the reaction at various time points,
mixed with SDS-PAGE loading buffer, and boiled. Samples
were resolved by SDS-PAGE and analyzed by Western blotting
using HRP-conjugated anti-T7 monoclonal antibody.
NMR spectroscopy
NMR data were acquired at 25 °C on a Bruker Avance III
600-MHz spectrometer equipped with a TXI-RT probe. Data
processing and analysis were carried out using NMRPipe (29)
and NMRView (30), respectively. For NMR chemical shift map-
ping, 2D 1H-15N HSQC spectra were acquired using 0.2 mM
15N-labeled SUMO-3 titrated with increasing molar ratios of
unlabeled PIASy. All titration samples contained 10% (v/v)
D2O. The published backbone amide assignment of SUMO-2/3
was used in the analysis (14, 31). The weighted CSD was calcu-
lated using 0.5[(H)2  (N/5)2]1/2 (32). Residues perturbed
during the titrations were mapped onto the NMR structure of
SUMO-3 (Protein Data Bank code 1U4A) (31).
Fluorescence polarization (FP)
Purified SUMO-3 and PIASy(287– 454) were dialyzed into
1 PBS buffer (phosphate-buffered saline, pH 7.4) overnight.
The single native cysteine of SUMO-3 (residue 47) was utilized
to covalently attach the fluorophore, fluorescein maleimide
(FM) following the manufacturer’s protocol (Invitrogen).
Briefly, a 20-fold molar excess of FM prepared in dimethyl sulf-
oxide was added to the tris(2-carboxyethyl)phosphine-reduced
protein and allowed to react in the dark at room temperature
for 3 h. The unbound excess dye was removed by extensive
dialysis in PBS followed by passage through an Amicon Ultra
3000 centrifugal filter. Increasing concentrations of PIASy
(0 –360 M) were titrated into 25 nM FM-labeled SUMO-3.
Samples were incubated at room temperature for 30 min, and
FP was measured with excitation and emission wavelengths of
492 and 515 nm, respectively, using a Varian Cary Eclipse fluo-
rescence spectrophotometer. G-factor-corrected polarization
values were obtained using the following formula.
P  IVV  G  IVH/IVV 	 G  IVH (Eq. 1)
Background fluorescence was subtracted from the average of
five data points, and the change in millipolarization (mP) was
plotted against increasing concentrations of PIASy. The disso-
ciation constant (Kd) was estimated by non-linear hyperbolic
fitting of the data using GraphPad Prism 5.0.
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